According to the evidence, in obese breast cancer patients, high leptin levels in plasma and overexpression of leptin receptors in tumors correlate positively with poor prognosis36,37; and mice genetically deficient for the leptin receptor do not develop oncogene-induced mammary tumors, as a result of defective leptin signaling38. The gene discussed is LEPR; the disease is breast cancer.